Galapagos NV (NASDAQ:GLPG) shares gapped up prior to trading on Tuesday . The stock had previously closed at $54.18, but opened at $54.51. Galapagos NV shares last traded at $55.13, with a volume of 23,112 shares changing hands.

A number of research analysts have recently weighed in on the company. Zacks Investment Research upgraded Galapagos NV from a “hold” rating to a “buy” rating and set a $67.00 price target for the company in a research report on Wednesday, June 8th. Credit Suisse Group AG restated a “hold” rating and issued a $48.00 price target on shares of Galapagos NV in a research report on Friday, June 17th. Morgan Stanley reiterated a “buy” rating and set a $89.00 price objective on shares of Galapagos NV in a research report on Monday, May 2nd. Finally, Cowen and Company reiterated a “buy” rating on shares of Galapagos NV in a research report on Saturday, April 30th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of €65.50 ($74.43).

The company’s market capitalization is $2.54 billion. The company has a 50 day moving average price of $53.94 and a 200-day moving average price of $49.16.

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.